Pfizer vs Johnson & Johnson: revenue, margins and growth
A pure pharmaceutical company against pharmaceuticals plus medical devices.
Below: each company's latest quarter against the same quarter a year earlier, and its valuation at the latest close. For the rest (segments, risks, five-year trends), connect Clarifo to ChatGPT and ask: every answer cites the filing it came from.
Pfizer and Johnson & Johnson: latest quarter
Each company's latest reported quarter against the same quarter a year earlier, in its reporting currency. Quarters are the companies' own fiscal quarters. Growth and margins are computed from the reported figures.
| Metric | PfizerQ2/2026 | Johnson & JohnsonQ3/2026 |
|---|---|---|
| Revenue | 15.0+2.6% | 25.4+5.9% |
| Profit before tax | -0.7 | 0.0-99.5% |
| Net profit | -0.2 | 0.2-95.9% |
| Earnings per share | -0.04 | 0.09-95.8% |
| Operating cash flow | 0.8 | 7.7-15.8% |
| Return on equity, 12 months | 5.0% | 20.0% |
| Equity ratio | 42.4%-0.7 pp | 41.3%+0.2 pp |
Amounts in USD billions; earnings per share in the same currency. The smaller line is the change from the same quarter a year earlier (pp = percentage points).
The two companies' latest quarters are different periods, because their fiscal years end on different dates or one has reported more recently.
Pfizer vs Johnson & Johnson valuation
Market value at the latest stored closing price. Multiples use the latest full fiscal year's earnings, revenue and cash flow; enterprise value adds net debt to market capitalisation. A dash means not available or not meaningful (for example a loss).
| Measure | PfizerClose 2026-10-23 | Johnson & JohnsonClose 2026-10-27 |
|---|---|---|
| Share price | 30.05 | 268.78 |
| Market capitalisation | 171.7 | 653.2 |
| P/E | 22.1 | 24.4 |
| EV/EBIT | 24.4 | – |
| EV/EBITDA | 14.5 | – |
| P/S | 2.7 | 6.9 |
| Free cash flow yield | 5.3% | 3.0% |
Market capitalisation in USD billions; share price in the same currency. Multiples are times earnings, EBIT, EBITDA or revenue of the latest full fiscal year (Pfizer FY 2025, Johnson & Johnson FY 2025).
Compare Pfizer and Johnson & Johnson in ChatGPT
With the Clarifo app connected, ChatGPT answers from the filings and links each figure to its source page. Open a question, or copy it into any assistant that has Clarifo.
- Revenue and margins
Compare Pfizer and Johnson & Johnson revenue and operating margin over the last five fiscal years. Show the figures from each 10-K.
- Segments
Which business segments drive Pfizer's and Johnson & Johnson's revenue, and how fast did each grow in the latest fiscal year? Use the segment notes.
- Cash flow
Compare Pfizer and Johnson & Johnson operating cash flow, capital expenditure and free cash flow for the latest fiscal year. Cite the cash flow statements.
- Risks
Which risk factors does Pfizer list in its latest 10-K that Johnson & Johnson does not, and the other way round? Quote the sections.
Each company in detail
Other companies people compare
- Eli Lilly vs Pfizer
- UnitedHealth vs CVS Health
- Apple vs Microsoft
- NVIDIA vs AMD
- AMD vs Intel
- NVIDIA vs Broadcom
Compare any two companies in ChatGPT
Clarifo gives ChatGPT the filings of 7,000+ US and Nordic public companies, with every figure linked to its source page.
Add Clarifo to ChatGPT